Cargando…
The role of dynamic phenotypes in cancer
The question of whether cancer recurrence is mediated by a process that is exclusively Darwinian or that involves both Darwinian and Lamarckian processes is long standing and far from answered. The major open question is the origin of variation, whether it relays exclusively on stable, mostly geneti...
Autores principales: | Lenz, Luana S., Lenz, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448515/ https://www.ncbi.nlm.nih.gov/pubmed/34548913 http://dx.doi.org/10.18632/oncotarget.28006 |
Ejemplares similares
-
Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
por: Schuessler‐Lenz, Martina, et al.
Publicado: (2019) -
Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
por: Sant, Grannum R., et al.
Publicado: (2017) -
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
por: Rovida, Elisabetta, et al.
Publicado: (2014) -
Long COVID-19 and the Role of the Patient–Clinician Interaction in Symptom Management
por: Calabrese, Leonard, et al.
Publicado: (2022) -
Accelerating aging with dynamic biomaterials: Recapitulating aged tissue phenotypes in engineered platforms
por: Madl, Christopher M.
Publicado: (2023)